How generative diffusion models synthesize entirely novel chemical scaffolds optimized simultaneously for potency, selectivity, and synthesizability.
With over 10^60 possible drug-like small molecules, human medicinal chemists explore only a minuscule fraction. Generative diffusion models explore novel chemical spaces far beyond traditional commercial catalogs.
Generative loops balance competing pharmacological objectives: maximizing nanomolar binding affinity to the target protein while ensuring high synthetic accessibility (SAScore) and minimal off-target promiscuity.
Generated molecules are validated using retrosynthetic planning algorithms (e.g., AiZynthFinder), ensuring that every suggested compound can be synthesized from readily available commercial precursors in fewer than five reaction steps.